Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

NCT00410072 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

669

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Entecavir
DRUG: Entecavir + Tenofovir

Sponsor

Bristol-Myers Squibb